Thursday, December 14, 2017
Text Size

Welfare Fund

New SwiftMD Benefit


IUOE Local 138 Welfare Fund has included SwiftMD in your

benefits package.

Download the Swift MD Welcome Letter here


 No co-pays or cost to you!

 877-999-7943 |


new substance abuse vendor

January 1, 2016



Dear Participant,


In order to better serve its participants and improve access to Substance Abuse treatment, effective January1st 2016, the Local 138 Substance Abuse benefits will be administered by Workforce Assistance Programs and the Workforce MAP Network of Providers


Substance Abuse benefit will be fully facilitated through Workforce Assistance Programs & Consulting.  Workforce in conjunction with MagnaCare will continue its tradition as established at Local 138 in past years by reaching out to the members and families offering them “Hope” when substance abuse problems affect our members and their families.


Network benefit, intervention and referral services for all  substance abuse treatment must be performed by Workforce Assistance Programs










You can access these vital benefits at Workforce Assistance Programs by calling



Workforce Assistance will certify and establish eligibility for members and dependents in need of Substance Abuse Treatment to the appropriate Workforce Network Provider. 


We’re Here!  We Care!   





New York State Hydrocodone Product Prescriptions

New Hydrocodone Product Prescription Requirement for New York State

Dear Valued Client:


We want to make you aware of an important market dynamic that may affect your plan members. This would affect any plan members who obtain prescriptions written by New York State prescribers.


On November 25, 2012, the state of New York made several changes to the state's controlled substance schedules.  Those changes included the reclassification of any product containing hydrocodone.  Effective February 23, 2013, all strengths, formulations, and combination products containing hydrocodone become Schedule II controlled substances in New York State.  Vicodin is likely the brand name medication you’re most familiar with containing hydrocodone. 


The new law is specific to the state of New York.  Even though the CVS Caremark Pharmacy is located in another state, if the prescription was written by a New York licensed prescriber, our pharmacy is obligated to follow the New York rules pertaining to the issuance and dispensing of the prescription.  If the initial prescription was sent to the pharmacy within 30 days from the date the prescription was written by the prescriber, the prescription is still valid.  However, if the prescription indicated that refills are permitted, those refills are not valid.  To obtain more hydrocodone medication, the patient must present a new hard-copy Official New York Prescription form from their prescriber.


If a prescription was written prior to February 23, 2013 that has already been filled for the initial fill, but had refills remaining, those refills would not be valid after February 23, 2013. 


Effective February 23, 2013, refills will no longer be allowed on any hydrocodone prescriptions. A new hard-copy prescription written on an Official New York Prescription form must be mailed by your patient to the CVS Caremark Mail Service and Specialty Pharmacies.  Regardless of the classification of hydrocodone in the state the prescription is dispensed, because the prescription was written by a New York prescriber, New York law applies to dispensing of the medication.


It is important to note that the federal classification of hydrocodone products remains unchanged. 


For more information on this issue, please visit the New York State Bureau of Narcotic Enforcement website at  It details all of the recent changes to New York's controlled substance schedules and includes additional information. You may also contact the U.S. Food and Drug Administration (FDA) consumer inquiry line at 1‑888-INFO-FDA (1-888-463-6332) or by accessing their Web site at

In response to this event, CVS Caremark Mail Service, CVS Caremark Specialty Pharmacies and CVS Retail Pharmacies are sending letters to health care providers who practice in New York State and their patients who take hydrocodone to notify them of this issue.

Please feel free to contact me if you have questions.




Manny Taveras | CVS Caremark | Account Executive Phone: (401) 305-9086 | Cell: (401) 572-9152 |  Fax: (401) 335-7032|  695 George Washington Highway, Lincoln, RI  02865 | This e-mail address is being protected from spambots. You need JavaScript enabled to view it


The women's health and cancer rights act - WHCRA

Dear Members:

In recognition of Breast Cancer Awareness Month, the Trustees of the Local 138, 138A, 138B & 138C Welfare Fund wish to remind you of the importance of regular screenings for Breast Cancer.

Get a Mammogram Every 1 to 2 Years

Take care of your health now, so you can be there for your family later. The Fund covers a Mammogram once every year for all women with a participating MagnaCare provider with a co-payment of only $20 and any non-participating provider the Fund will pay 70% of the Reasonable and Customary (R&C) charges after a yearly $300 deductible has been met.

Who should get one?

Women in their 40s and older should get a mammogram every 1 to 2 years. A woman's chance of getting breast cancer is greater as she ages.

Are you at risk for breast cancer?

Simply being a woman and getting older puts you at risk for breast cancer. The older you are, the greater your chances of getting breast cancer. Also, you are at higher risk if your mother, sister, or daughter has had breast cancer.

Finding the disease early with mammograms and breast exams by your doctor or nurse can save your life. For yourself and your family, call your doctor for an exam and mammogram today.

Acknowledgement given to the National Cancer Institute as originator of the information provided herein, with the NCI web site as the source.

The Fund also provides coverage for mastectomy related procedures.  Coverage will be provided in a manner determined in consultation with your attending physician for the following services:

* All stages of reconstruction of the breast on which the mastectomy was performed;
* Surgery and reconstruction of the other breast to produce a symmetrical appearance;
* Prostheses; and
* Treatment of physical complications of the mastectomy, including lymphedema.

These benefits will be provided subject to the same deductibles and coinsurance applicable to other medical and surgical benefits provided under the Plan.  Therefore, the following deductibles and coinsurance apply; The Fund will pay 90% of the R&C for a MagnaCare In-network facility and/or surgeon and 70% after a yearly $300 deductible for a non-participating facility and/or surgeon (a $20 co-pay applies for all office based surgeries).

If you would like more information on WHCRA benefits, please contact the Fund Office at 631.694-2480 option 2